PATENT CLAIM ANALYSIS

Application Number: 16195264
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "283000"]

Abstract:
The present invention provides SN-38 compositions for treating cancer.

Claim (Index 14):
The composition according to  claim 13 , wherein the 7-ethyl camptothecin is between about 0.0001 and about 0.04 weight percent of the composition, the 10-hydroxy camptothecin is between about 0.00005 and about 0.02 weight percent of the composition, and the 10-hydroxy-7-methyl camptothecin is between about 0.00005 and about 0.02 weight percent of the composition.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15892216', '14204698', '14669611', '14674117', '14656200']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6789397923055086
- 35 USC 102 Novelty (BERT): 0.5594119488967692
- Combined Prediction Score: 0.6669870079646347
- Mean Citation Score: 215.021208
- Max Citation Score: 399.29816
- Similarity Product: 396.90487708743103

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test